General Inception acquires Enable Medicine and announces strategic partnership to accelerate drug discovery with AI-led generative biological search
- Enable Medicine is at the forefront of using generative AI models to search vast cellular atlases of disease to discover new therapeutic insights
- Partnership will greatly boost the two companies’ drug discovery and development capabilities
- It comes after their first collaboration that led to Ennovate Pharma SAS, working on highly promising targets in autoimmune and inflammatory diseases
PALO ALTO, CA, & MENLO PARK, CA – 12 December 2024 – General Inception, a global biotech company igniter, and Enable Medicine, a leader in AI-led data analysis for biological research and drug discovery, today announce an equity and strategic partnership which will amplify their joint drug discovery capabilities. As part of this partnership, General Inception is acquiring Enable for an undisclosed amount.
